
DEL-22379
CAS No. 181223-80-3
DEL-22379 ( DEL22379 | DEL 22379 )
产品货号. M12782 CAS No. 181223-80-3
一种 ERK 二聚化小分子抑制剂,IC50 为 0.5 uM,不影响 ERK 磷酸化。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥348 | 有现货 |
![]() ![]() |
5MG | ¥551 | 有现货 |
![]() ![]() |
10MG | ¥1021 | 有现货 |
![]() ![]() |
25MG | ¥1863 | 有现货 |
![]() ![]() |
50MG | ¥2989 | 有现货 |
![]() ![]() |
100MG | ¥4447 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称DEL-22379
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种 ERK 二聚化小分子抑制剂,IC50 为 0.5 uM,不影响 ERK 磷酸化。
-
产品描述A small molecule inhibitor of ERK dimerization with IC50 of 0.5 uM, without affecting ERK phosphorylation; prevents tumorigenesis by RAS-ERK pathway oncogenes.
-
体外实验DEL-22379 is an ERK dimerization inhibitor. DEL-22379 abolishes EGF-induced co-immunoprecipitation of ectopic ERK2 molecules tagged with hemagglutinin (HA) or FLAG epitopes, with an estimated half-maximal inhibitory concentration (IC50) of ~0.5 μM. DEL-22379 inhibits growth of tumor cells harboring RAS-ERK pathway oncogenes. The biological effects of DEL-22379 are investigated on tumor cells in culture. The cytostatic effects of DEL-22379 are compared to those of the MEK inhibitor PD-0325901 and the ERK kinase inhibitor SCH-772984, as reflected by their half-maximal growth inhibitory concentrations (GI50). Cell lines harboring mutant BRAF are the most sensitive to the three compounds. In comparison, wild-type (WT) cell lines for BRAF and RAS are the most resistant, and RAS mutant cells exhibit a range of sensitivities. In cells showing different oncogenic genotypes, distinct sensitivity to DEL-22379 can not be attributed to variations on its effects on dimerization, because DEL-22379 displays similar dimerization- and cytoplasmic signaling-inhibitory dose responses (IC50 of 150-400 nM) regardless of the genotype.
-
体内实验To test DEL-22379 antitumor effects, some of the aforementioned cell lines are xenografted into nude mice, and tumor growth is monitored after intra-peritoneal administration of DEL-22379 at 15 mg/kg. At such a dose, inhibition of ERK dimerization is evident in liver extracts and in xenografted tumors. DEL-22379 markedly inhibits tumor progression for A375 cells (BRAF mutant).
-
同义词DEL22379 | DEL 22379
-
通路MAPK/ERK Signaling
-
靶点ERK
-
受体ERK
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number181223-80-3
-
分子量444.5255
-
分子式C26H28N4O3
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 30 mg/mL
-
SMILESO=C(NC1=CC2=C(NC(/C2=C/C3=CNC4=C3C=C(OC)C=C4)=O)C=C1)CCN5CCCCC5
-
化学全称1-Piperidinepropanamide, N-[2,3-dihydro-3-[(5-methoxy-1H-indol-3-yl)methylene]-2-oxo-1H-indol-5-yl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Herrero A, et al. Cancer Cell. 2015 Aug 10;28(2):170-82.